SYB-010

N/A

Report date: 2024/02/06 16:32:23
First In Class

Base Information

Drug NameSYB-010
Drug Alias NameCuraB-10SYB-010HuB10G5
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunostimulantsNatural killer cells stimulantsT lymphocytes stimulants +[4] 
TargetsNKG2D ligands
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCancure
China Registration ClassN/A

Develop Information

Active CompaniesCancureSamyang Biopharm USA IncSpanish National Research Council
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A